The efficacy and safety of edoxaban versus warfarin in preventing clinical events in atrial fibrillation: A systematic review and meta-analysis
Xiangwen Liang, Wenchao Xie, Zhihai Lin, Ming LiuDepartment of Cardiology, the First People’s Hospital of Yulin, the Sixth Affiliated Hospital of Guangxi Medical University; Guangxi-ChinaKeywords: edoxaban, warfarin, atrial fibrillation, meta-analysis
Xiangwen Liang, Wenchao Xie, Zhihai Lin, Ming Liu. The efficacy and safety of edoxaban versus warfarin in preventing clinical events in atrial fibrillation: A systematic review and meta-analysis. Anatol J Cardiol. 2021; 25(2): 77-88
Corresponding Author: Ming Liu, China
Corresponding Author: Ming Liu, China
| TOOLS |
 Full Text PDF Print Download citation RIS EndNote BibTex Medlars Procite Reference Manager Share with email Share Send email to author
Similar articles PubMed Google Scholar |